Euglena Co., Ltd. (TYO:2931)

Market Cap	59.47B
Revenue (ttm)	48.40B
Net Income (ttm)	-1.35B
Shares Out	136.39M
EPS (ttm)	-9.89
PE Ratio	n/a
Forward PE	215.31
Dividend	n/a
Ex-Dividend Date	n/a

Volume	955,400
Average Volume	719,685
Open	448.00
Previous Close	455.00
Day's Range	435.00 - 455.00
52-Week Range	381.00 - 581.00
Beta	-0.11
RSI	43.48
Earnings Date	May 12, 2025

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It also manufactures and sells foods and cosmetics using euglena. In addition, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. Further, it produces, processes, and sells euglena, chlorella, watermelon, midori koji, etc.; and manufactures and sells organic fertilizer. Additionally, the company provides genome analysis services. Euglena Co., Ltd. was incorp...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2005
• Employees: 897
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2931

Financial Performance

In 2024, Euglena's revenue was 47.62 billion, an increase of 2.44% compared to the previous year's 46.48 billion. Losses were -650.00 million, -75.49% less than in 2023.